Jellagen Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Jellagen General Information
Description
Developer of collagen products designed to address complex tissue engineering and regenerative medical needs. The company's products offer non-mammalian jellyfish collagen ranging from in-vitro to in-vivo applications, as well as a batch-to-batch consistency offering advantages to research and medical applications, enabling medicinal researchers to conduct in-house research and development and supporting the fabrication of new medical devices offering new approaches to wound management and tissue engineering.
Contact Information
Website
www.jellagen.co.ukCorporate Office
- Unit G6, Capital Business Park
- Parkway, Saint Mellons
- Cardiff CF3 2PY
- Wales, United Kingdom
Corporate Office
- Unit G6, Capital Business Park
- Parkway, Saint Mellons
- Cardiff CF3 2PY
- Wales, United Kingdom
Jellagen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series A) | 08-Dec-2022 | Completed | Generating Revenue | |||
| 8. Angel (individual) | 01-Mar-2022 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 25-Jun-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 09-Apr-2019 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 20-Feb-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 27-Apr-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 15-Dec-2016 | Completed | Startup | |||
| 2. Early Stage VC | 02-Sep-2015 | $895K | $895K | Completed | Startup | |
| 1. Grant | 17-Aug-2015 | $3.07M | Completed | Startup |
Jellagen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| B Preferred Ordinary | ||||||||
| A Ordinary | ||||||||
| Preferred Ordinary | ||||||||
| Ordinary | ||||||||
| A Ordinary | ||||||||
| Preferred Ordinary | ||||||||
| Preferred Ordinary | 4,227 | $0.011933 | $112.93 | $112.93 | 1x | $112.93 | 2.92% | |
| A Ordinary | 1,849 | $0.011933 | $112.93 | $112.93 | 1x | $112.93 | 1.28% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Jellagen Comparisons
Industry
Financing
Details
Jellagen Competitors (10)
One of Jellagen’s 10 competitors is Fidia Farmaceutici, a Formerly PE-Backed company based in Abano Terme, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fidia Farmaceutici | Formerly PE-Backed | Abano Terme, Italy | ||||
| ARVYS Proteins | Corporation | Trumbull, CT | ||||
| ProSpec-Tany TechnoGene | Corporation | East Brunswick, NJ | ||||
| Encoll | Corporation | Fremont, CA | ||||
| SYMATESE | Formerly PE-Backed | Chaponost, France |
Jellagen Patents
Jellagen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026038012-A1 | Modified proteins and methods of manufacture thereof | Pending | 16-Aug-2024 | ||
| GB-202405695-D0 | Marine invertebrate collagen use | Inactive | 19-Apr-2024 | ||
| WO-2025219725-A1 | Marine invertebrate collagen use | Pending | 19-Apr-2024 | ||
| JP-7867012-B2 | Collagen extract for use as a pharmaceutical product | Active | 04-Mar-2021 | ||
| JP-2024511299-A | Collagen extract for use as medicine | Active | 04-Mar-2021 | A61K35/614 |
Jellagen Signals
Jellagen Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cardiff Capital Region | Infrastructure | Minority | ||
| Thai Union Group | Corporation | Minority | ||
| Angels Invest Wales | Angel Group | Minority | ||
| MedCity | Corporation | Minority | ||
| Newable Partnership | Growth/Expansion | Minority |
Jellagen FAQs
-
When was Jellagen founded?
Jellagen was founded in 2013.
-
Where is Jellagen headquartered?
Jellagen is headquartered in Cardiff, United Kingdom.
-
What is the size of Jellagen?
Jellagen has 13 total employees.
-
What industry is Jellagen in?
Jellagen’s primary industry is Pharmaceuticals.
-
Is Jellagen a private or public company?
Jellagen is a Private company.
-
What is Jellagen’s current revenue?
The current revenue for Jellagen is .
-
How much funding has Jellagen raised over time?
Jellagen has raised $24.3M.
-
Who are Jellagen’s investors?
Cardiff Capital Region, Thai Union Group, Angels Invest Wales, MedCity, and Newable Partnership are 5 of 11 investors who have invested in Jellagen.
-
Who are Jellagen’s competitors?
Fidia Farmaceutici, ARVYS Proteins, ProSpec-Tany TechnoGene, Encoll, and SYMATESE are some of the 10 competitors of Jellagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process